Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
The Journal of Pharmacy and Pharmacology|June 29, 1999
Halofantrine metabolism in microsomes in man: major role of CYP 3A4 and CYP 3A5B Baune, J P Flinois, V Furlan, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1989
Diffusion of ofloxacin into cerebrospinal fluid of patients with purulent meningitis or ventriculitisJ C Pioget, M Wolff, E Singlas, et al.
Ultrasound in Medicine & Biology|May 23, 2001
Human pharmacokinetics of a perfluorocarbon ultrasound contrast agent evaluated with gas chromatographyJ M Correas, A R Meuter, E Singlas, et al.
European Journal of Clinical Pharmacology|January 1, 1982
Pharmacokinetics of sulfamethoxazole--trimethoprim combination during chronic peritoneal dialysis: effect of peritonitisE Singlas, J N Colin, J Rottembourg, et al.
Zeitschrift Fur Kardiologie|January 1, 1985
Diuretic effect and pharmacokinetic data observed at different stages of chronic renal failure with 240 mg of muzolimineA Baumelou, E Singlas, W Ritter, et al.
Journal of Clinical Pharmacy and Therapeutics|November 25, 2014
Worsening pneumonitis due to a pharmacokinetic drug-drug interaction between everolimus and voriconazole in a renal transplant patientC Lecefel, P Eloy, B Chauvin, et al.
Antimicrobial Agents and Chemotherapy|December 10, 2009
Influence of alpha-1 glycoprotein acid concentrations and variants on atazanavir pharmacokinetics in HIV-infected patients included in the ANRS 107 trialA Barrail-Tran, F Mentré, C Cosson, et al.
Steroids|February 1, 1980
Carbon-13 nuclear magnetic resonance studies of spironolactone and several related steroidsR J Highet, T R Burke, W F Trager, et al.
Clinical Pharmacology and Therapeutics|October 4, 2012
Effect of adherence as measured by MEMS, ritonavir boosting, and CYP3A5 genotype on atazanavir pharmacokinetics in treatment-naive HIV-infected patientsR M Savic, A Barrail-Tran, X Duval, et al.
Antimicrobial Agents and Chemotherapy|March 26, 2014
Pharmacokinetics of rifampin and isoniazid in tuberculosis-HIV-coinfected patients receiving nevirapine- or efavirenz-based antiretroviral treatmentN B Bhatt, C Barau, A Amin, et al.
Pageof 9